HLTH: Redefining Clinical Trials: Sasha Tyndale on Inclusive Research at AbbVie
Diseases don't discriminate, so it is crucial that medicines are accessible to and effective for as many people as possible.
In this episode, Sasha Tyndale, Director of Diversity and Patient Inclusion at AbbVie, discusses the company’s commitment to inclusive clinical research, highlighting the importance of representing diverse populations affected by diseases. Sasha shares how her team integrates patient perspectives into clinical program design to proactively address potential barriers. She introduces the ADMIRE program, which is focused on engaging underrepresented healthcare professionals in research. Sasha also emphasizes humanizing the healthcare experience by hearing patient stories and addressing challenges. She delves into AbbVie's bold initiatives, including foundational changes to clinical development processes and partnerships with community organizations to increase access to clinical trials and simplify language in study materials. Finally, Sasha challenges listeners to educate themselves and others about clinical research.
Tune in and learn how to become an advocate for inclusive healthcare!
About Sasha Tyndale:
Sasha Tyndale is a seasoned leader in the pharmaceutical industry with over 20 years of experience spanning oncology, immunology, neuroscience, and more. As Director of Diversity and Patient Inclusion at AbbVie, she drives patient-centric strategies and innovative clinical operations. With expertise in precision medicine and personalized healthcare, she collaborates cross-functionally to enhance patient engagement and future-proof organizations. Previously, she held key roles at PAREXEL and Johnson & Johnson, specializing in strategic patient recruitment and clinical innovation. Sasha holds a Master’s and Bachelor’s degree in English Literature from Rutgers University. Passionate about advancing equitable healthcare, she is committed to transforming research and improving patient outcomes.
Things You’ll Learn:
AbbVie is making clinical trials more inclusive by ensuring they represent diverse populations affected by the diseases being studied.
Through programs like ADMIRE, AbbVie is expanding research access by involving underrepresented healthcare providers in clinical research.
AbbVie is simplifying participation in clinical trials by making study materials clearer and designing studies that minimize patient burden.
Patient voices are essential in humanizing research, providing valuable insights into real-life disease challenges, and encouraging greater participation in clinical trials.
AbbVie is taking bold action to challenge traditional research practices, collaborate with community partners, and improve healthcare access and representation.
Educating individuals about clinical trials empowers communities to make informed decisions about participation in medical research.
Resources:
